168 related articles for article (PubMed ID: 36629093)
1. Prognosis prediction and risk factors for triple-negative breast cancer patients with brain metastasis: A population-based study.
Yang Y; Zhang L; Tian W; Li Y; Qin Q; Mao Y; Liu X; Hong J; Hu L; Zeng Q; Zhang Q; Zhao H
Cancer Med; 2023 Apr; 12(7):7951-7961. PubMed ID: 36629093
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
[TBL] [Abstract][Full Text] [Related]
3. A Web-based Prediction Model for Early Death in Patients With Metastatic Triple-negative Breast Cancer.
Pan WK; Ren SY; Zhu LX; Lin BC
Am J Clin Oncol; 2024 Feb; 47(2):71-80. PubMed ID: 37871164
[TBL] [Abstract][Full Text] [Related]
4. Prognosis of Patients With Triple-negative Breast Cancer: A Population-based Study From SEER Database.
Zhou HL; Chen DD
Clin Breast Cancer; 2023 Apr; 23(3):e85-e94. PubMed ID: 36669957
[TBL] [Abstract][Full Text] [Related]
5. Establishment and verification of a nomogram to predict tumor-specific mortality risk in triple-negative breast cancer: a competing risk model based on the SEER cohort study.
Li Z; Shi Y; Wu L; Zhang H; Xue J; Li W; Wang X; Zhang L; Wang Q; Duo L; Wang M; Wang G
Gland Surg; 2022 Dec; 11(12):1961-1975. PubMed ID: 36654948
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Prognostic Nomograms for Lung Metastasis in Triple-Negative Breast Cancer.
Wang J; Zhao H; Ye L; Li J; Zhang H; Zhang C; Rao Q; Cai Y; Xu Y; Deng Y
Comput Math Methods Med; 2022; 2022():1750834. PubMed ID: 35991145
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome assessment for triple-negative breast cancer: a nomogram analysis based on integrated clinicopathological, sonographic, and mammographic characteristics.
Sheng DL; Shen XG; Shi ZT; Chang C; Li JW
Eur Radiol; 2022 Oct; 32(10):6575-6587. PubMed ID: 35759017
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological features and prognostic evaluation of bone metastasis in triple-negative breast cancer.
Luo A; Wu F; Han R; Huang S; Zhang Y; Jing X; Zhao X
J Cancer Res Ther; 2017; 13(5):778-784. PubMed ID: 29237903
[TBL] [Abstract][Full Text] [Related]
9. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
10. A risk stratification model for predicting brain metastasis and brain screening benefit in patients with metastatic triple-negative breast cancer.
Lin M; Jin Y; Jin J; Wang B; Hu X; Zhang J
Cancer Med; 2020 Nov; 9(22):8540-8551. PubMed ID: 32945619
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of male triple negative breast cancer: A population-based study.
Ghani S; Sochat M; Luo J; Tao Y; Ademuyiwa F
Breast J; 2020 Sep; 26(9):1748-1755. PubMed ID: 32856383
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic nomograms for newly diagnosed intrahepatic cholangiocarcinoma with brain metastasis: A population-based analysis.
Liu Z; Yi J; Yang J; Zhang X; Wang L; Liu S
Exp Biol Med (Maywood); 2022 Sep; 247(18):1657-1669. PubMed ID: 35946168
[TBL] [Abstract][Full Text] [Related]
13. Influence of advanced age on the prognosis of triple-negative breast cancer patients: A surveillance, epidemiology, and end results-based study.
Tan H; Fu D
J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147967
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database.
Tang Z; Ji Y; Min Y; Zhang X; Xu W; Zhao L; Zhang J; Long L; Feng J; Wen Y
Front Endocrinol (Lausanne); 2022; 13():856268. PubMed ID: 35370936
[TBL] [Abstract][Full Text] [Related]
15. Nomogram for predicting survival in triple-negative breast cancer patients with histology of infiltrating duct carcinoma: a population-based study.
Dai D; Jin H; Wang X
Am J Cancer Res; 2018; 8(8):1576-1585. PubMed ID: 30210925
[TBL] [Abstract][Full Text] [Related]
16. A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer.
Meng X; Cai Y; Chang X; Guo Y
Front Endocrinol (Lausanne); 2023; 14():1119105. PubMed ID: 36909305
[TBL] [Abstract][Full Text] [Related]
17. Nomogram for predicting overall survival in patients with triple-negative apocrine breast cancer: Surveillance, epidemiology, and end results-based analysis.
Xu Y; Zhang W; He J; Wang Y; Chen R; Shi W; Wan X; Shi X; Huang X; Wang J; Zha X
Breast; 2022 Dec; 66():8-14. PubMed ID: 36084385
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for distant metastasis of patients with primary triple-negative breast cancer.
Yao Y; Chu Y; Xu B; Hu Q; Song Q
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113872
[No Abstract] [Full Text] [Related]
19. Predictive value of a nomogram for melanomas with brain metastases at initial diagnosis.
Liu H; Xu YB; Guo CC; Li MX; Ji JL; Dong RR; Zhang LL; He XX
Cancer Med; 2019 Dec; 8(18):7577-7585. PubMed ID: 31657530
[TBL] [Abstract][Full Text] [Related]
20. Treatment response as predictor for brain metastasis in triple negative breast cancer: A score-based model.
Gabani P; Weiner AA; Hernandez-Aya LF; Khwaja S; Roach MC; Ochoa LL; Mullen D; Thomas MA; Matesa MA; Margenthaler JA; Cyr AE; Naughton MJ; Ma C; Sanati S; Zoberi I
Breast J; 2019 May; 25(3):363-372. PubMed ID: 30920124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
